MGGLX
Price
$35.41
Change
+$0.18 (+0.51%)
Updated
Dec 3 closing price
Net Assets
3.31B
RNPCX
Price
$71.95
Change
+$0.37 (+0.52%)
Updated
Dec 3 closing price
Net Assets
162.64B
Interact to see
Advertisement

MGGLX vs RNPCX

Header iconMGGLX vs RNPCX Comparison
Open Charts MGGLX vs RNPCXBanner chart's image
Morgan Stanley Inst Global Opp L
Price$35.41
Change+$0.18 (+0.51%)
VolumeN/A
Net Assets3.31B
American Funds New Perspective R3
Price$71.95
Change+$0.37 (+0.52%)
VolumeN/A
Net Assets162.64B
MGGLX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
MGGLX vs. RNPCX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGGLX is a Buy and RNPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 163B vs. MGGLX (3.31B). RNPCX pays higher dividends than MGGLX: RNPCX (0.21) vs MGGLX (0.00). MGGLX was incepted earlier than RNPCX: MGGLX (18 years) vs RNPCX (24 years). MGGLX (1.74) is less costly to investors than RNPCX (1.06). RNPCX is a more actively managed with annual turnover of: 24.00 vs. MGGLX (19.00). RNPCX has a lower initial minimum investment than MGGLX: RNPCX (250) vs MGGLX (1000). RNPCX annual gain was more profitable for investors over the last year : 11.50 vs. MGGLX (-2.29). RNPCX return over 5 years is better than : 22.60 vs. MGGLX (-15.85).
MGGLXRNPCXMGGLX / RNPCX
Total Expense Ratio1.291.06122%
Annual Report Gross Expense Ratio1.741.06164%
Fund Existence18 years24 years-
Gain YTD11.59819.77759%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.31B163B2%
Annual Yield % from dividends0.000.21-
Returns for 1 year-2.2911.50-20%
Returns for 3 years40.6843.9793%
Returns for 5 years-15.8522.60-70%
Returns for 10 years118.7290.03132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNM1.450.07
+5.07%
Actinium Pharmaceuticals
AXSM147.815.72
+4.03%
Axsome Therapeutics
ARLO14.270.38
+2.74%
Arlo Technologies
TLSI6.43-0.02
-0.31%
TriSalus Life Sciences
MNSBP24.85-0.12
-0.50%
MainStreet Bancshares